Home › Liver Diseases › NCT03193151
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
RecruitingObservational study
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation, a Multicenter Study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * biopsy for clinical indications Exclusion Criteria: * no consent, pregnant women
About the study
INTERLIVER is a prospective observational study of the relationship of the molecular phenotype of 300 liver transplant biopsies to the histologic phenotype and the clinical features and outcomes. A segment of a biopsy performed as standard-of-care for indications, or by center protocol, will be used for gene expression study.
What is being tested
- liver biopsy (procedure)
Sponsor: University of Alberta · Participants: 300 · Started: Dec 19, 2017
Contact the study team
- Konrad S Famulski, PhD · Phone: 1 780 492 1725
- Robert Polakowski, PhD · Phone: 1 780 492 5091
Official record on ClinicalTrials.gov — NCT03193151
Locations in the U.S.
| Michigan | Henry Ford Transplant Institute, Detroit |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.